Response to "Unexpected mutations after CRISPR-Cas9 editing in vivo"
Nat Methods
.
2018 Apr;15(4):236-237.
doi: 10.1038/nmeth.4552.
Epub 2018 Mar 30.
Authors
Christopher J Wilson
1
,
Tim Fennell
2
,
Anne Bothmer
1
,
Morgan L Maeder
1
,
Deepak Reyon
1
,
Cecilia Cotta-Ramusino
1
,
Cecilia A Fernandez
1
,
Eugenio Marco
1
,
Luis A Barrera
1
3
,
Hariharan Jayaram
1
,
Charles F Albright
1
,
Gerald F Cox
1
,
George M Church
4
,
Vic E Myer
1
Affiliations
1
Editas Medicine, Cambridge, Massachusetts, USA.
2
Fulcrum Genomics, Somerville, Massachusetts, USA.
3
Arrakis Therapeutics, Waltham, Massachusetts, USA.
4
Harvard Medical School, Boston, Massachusetts, USA.
PMID:
29600989
DOI:
10.1038/nmeth.4552
No abstract available
Publication types
Comment
MeSH terms
CRISPR-Cas Systems*
Clustered Regularly Interspaced Short Palindromic Repeats*
Gene Editing
Mutation